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Abstract
Background: FBG2 (F-BOX6) gene is an important member in ubiquitin metabolic system F-BOX
family, and forms E3 complex with the other members in the family. But its role in gastric cancer
is still not clear. In the present study, we intended to investigate the influence of FBG2 on the
growth, proliferation, apoptosis, invasion and cell cycle of the gastric cancer line MKN45 and gastric
cell line HFE145.
Methods: As a critical component of ubiquitin-protein ligase complex, FBG2 cDNA was subcloned
into a constitutive vector PCDNA3.1 followed by transfection in MKN45 and HFE145 by using
liposome. Then stable transfectants were selected and appraised. The apoptosis and cell cycles of
these clones were analyzed by using flow cytometry. The growth and proliferation were analyzed
by cell growth curves and colony-forming assay respectively. The invasion of these clones was
tested by using cancer cell migration assay. The FBG2 stable expression clones(MKN-FBG2 and
HFE-FBG2) and their control groups were detected and compared respectively.
Results: MKN-FBG2 grew faster than MKN45 and MKN-PC(MKN45 transfected with PCDNA3.1
vector). HFE-FBG2 grew faster than HFE145 and HFE-PC(HFE145 transfected with PCDNA3.1
vector). The cell counts of MKN-FBG2 in the forth, fifth, sixth and seventh days were significantly
more than those of others (P < 0.05). Cell cycle analysis showed that MKN-FBG2 and HFE-FBG2
proliferated faster, proportions of cells in G2-M and S were different significantly with control
groups (P < 0.05). Results of colony-forming assay showed that the colony formation rates of MKN-
FBG2 and HFE-FBG2 were higher than those of control groups (P < 0.05). The results of cell
migration assay were all negative.
Conclusion: FBG2 can promote the growth and proliferation of gastric cancer cells and normal
gastric cells. It can help tumor cell maintain malignant phenotype too. But it can have a negative
influence on the apoptosis or the ability of invasion of gastric cancer cells.
Background
F-box proteins, a critical component of the evolutionary
conserved ubiquitin-protein ligase complex SCF (Skp1/
Cdc53-Cullin1/F-box), recruit substrates for ubiquitina-
tion and consequent degradation through their specific
protein-protein interaction domains. There are five F-box
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proteins previously identified, such as NFB42 (FBX2),
FBG2 (FBX6), FBG3, FBG4 and FBG5. All five proteins are
characterized by an approximately 180-aminoid(aa) con-
served C-terminal domain and thus constitute a third sub-
family of mammalian F-box proteins. FBG2 (F-BOX6)
gene is an important member in ubiquitin metabolic sys-
tem F-BOX family [1,2], and forms E3 complex with the
other members in the family. It has been proved in previ-
ous researches that ubiquitin metabolic system is an
important pathway for the catabolism of some protein
molecules in cells, such as products of many oncogenes
and anti-oncogenes [3-5], which enter metabolic system
through the identification by the members of F-BOX fam-
ily in E3 complex. It has been confirmed by small interfer-
ing RNA that FBG2 is a novel member of F-box protein
family which recognizes N-glycans and plays a role in the
endoplasmic reticulum-associated degradation
(ERAD)[6]. The changes in the expression of FBG2 gene in
cells may affect the expression level of some oncogenes or
anti-oncogenes so as to influence some biological charac-
ters of cells to some degree. Some cDNA gene chips were
used to detect the difference in gene expression between
gastric adenocarcinoma and the morphologically normal
mucosa tissues near carcinoma in our previous research
[7,8]. It was found that the expression level of FBG2 gene
in carcinoma tissues was higher than that in normal tis-
sues. However, there has been no report on the functions
of this gene in gastric cancer cells previously. In this
research, gene transfection method was used to introduce
FBG2 gene into gastric adenocarcinoma cell strain
MKN45 and normal gastric cell strain HFE145, then the
cell strains with stable expression were selected out. The
changes in the biological characters of the cell strains were
detected in order to perform a preliminary analysis on the
functions of this gene in gastric cancer cell.
Methods
Materials
Gastric adenocarcinoma cell line MKN45 was provided by
Shanghai Institute of Biotechnology and preserved by our
department. Gastric cell line HFE145 was preserved by
our department[9]. FBG2 monoclonal antibody was pur-
chased from Abcam company (USA), PCDNA3.1 vector
was preserved by our department, common cell culture
plates were purchased from Orange Company(Belgium).
Transwell cell culture plates were purchased from Castar
Company(USA). AnexinV-FITC apoptosis detection kit
was purchased from Beijing Biosea Biotechnology Co.,
Ltd. All the primers used in this research were synthesized
by Shanghai Boya Biotechnology Co., Ltd.
Expression of FBG2 gene in MKN45 and HFE145
Expressions of FBG2 gene in gastric adenocarcinoma cell
strain MKN45 and normal gastric cell strain HFE145 were
detected to determine whether the cell lines could used in
the research. RT-PCR and immunocytochemical assay
were performed to detect the expression of FBG2 in cells,
and the results showed that these cell strain were all FBG2
defective cell strains, which were suitable for gene trans-
fection experiment in the research.
Construction and identification of PC-FBG2 vector
The cDNA of FBG2 gene was obtained by RT-PCR from
total RNA of human gastric adenocarcinoma tissues
which was used as the templet for PCR. Inner and external
primers for nested PCR were synthesized respectively: S: 5'
GGGGTACCCCAGGCCATGGATGCTC 3' 129 A: 5'
CGGGATCCAACCGGGGCAGGAGTCG 3' 1104 (external
primer) S: 5' GGGGTACCATGGATGCTCCCCACTC 3'
136 A: 5' CGGGATCCATGGACAGCTGTCAGAA 3' 1024
(Inner primer)
With the templet of total RNA from gastric adenocarci-
noma tissues, nested PCR was performed to obtain the
CDS double strand DNA fragments of FBG2 gene with
KpnI and BamHI restriction sites in the two ends after two
cycles of reactions. KpnI and BamHI were used to incise
this double strand fragments and PCDNA3.1 vector. After
these incised products were purified, they were kept at
16°C over night for ligation under the actions of T4 ligase.
Then the ligated products were used to transform DH5α
competent cells, and antibiotic screening was performed.
PCR identification was conducted to select positive
clones. After amplification culture, positive clones were
identified by KpnI and BamHI incision. The confirmed
positive clones were sent for sequencing, and eukaryon
vectors PC-FBG2 with completely correct sequence of
FBG2 gene were obtained.
Transfection of PC-FBG2 vector in MKN45 and HFE145 
cells
DMEM culture medium with 10% fetal calf serum was
used to culture the MKN45 and HFE145 cells in 12-well
cell culture plates until the cells covered 90%–95% of the
area. Serum-free DMEM was used for culture over night.
Lipofectamine2000 liposome transfection kit was used.
According to the directions for use, liposome and PC-
FBG2 vector DNA were mixed and added into each well.
PCDNA3.1 empty vector transfection group and blank
control group (only liposome was added, and there was
no vector DNA) were established. Transfection was com-
pleted after 24 hours' incubation.
Selection of cell strains with stable expression of FBG2
Transfected cells were diluted the into 24-well culture
plates according to the proportion of 1:20. Then they were
selected in medium containing G418. The concentration
of G418 was based on the results of preliminary tests (800
μg/ml for MKN45 and 1000 μg/ml for HFE145, the con-
centration at which there were no surviving cells at 7 daysJournal of Experimental & Clinical Cancer Research 2009, 28:78 http://www.jeccr.com/content/28/1/78
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after the time when cells covered 90% of the area of the
wells in 6-well culture plate). The selection process con-
tinued for 31 days to allow colony formation. Colonies
resistant to G418 were isolated with cloning cylinders and
transferred into 24-well dishes. 12 and 7 positive clones
were respectively obtained in the PC-FBG2 vector transfec-
tion group(MKN-FBG2) and PCDNA3.1 empty vector
transfection group(MKN-PC) in MKN45 cell line. Then 9
and 5 positive clones were obtained respectively(HFE-
FBG2 and HFE-PC) in the two transfection groups in
HFE145 cell line. These selected clones were taken for
identification and frozen for future use.
Analysis of transfectants
RT-PCR and Western blotting analysis were respectively
performed to detect the mRNA and protein of FBG2, and
immunocytochemical analysis was used to detect the
expression of FBG2 protein in situ.
Cell growth curve assay
All of 12 MKN-FBG2 cell clones and 9 HFE-FBG2 which
stable expressed FBG2 were used. 12 clones which were
transfected by PCDNA3.1 empty vector and untreated cell
strains were used as control groups. The cells of each clone
were inoculated into 24-well culture plate at the concen-
tration of 5 × 104/ml. After the cells completely adhered to
the wall, they were washed once with PBS and then
trypsinized in 0.5 ml of Trypsin/EDTA and counted in
triplicates at 1 to 7 day using a cell counter (Beckman
Coulter, Inc., Fullerton, CA). The mean values of all 12
MKN-FBG2 cell clones and 9 HFE-FBG2 on different time
were calculated, and growth curves were plotted. In addi-
The Immunohistochemistry results of FBG2 in MKN45 cell  and HFE145 cell Figure 2
The Immunohistochemistry results of FBG2 in 
MKN45 cell and HFE145 cell. A: There was no postive 
signal in MKN45 cell. The result showed that there was no 
expression of FBG2 gene in MKN45 cell. B: There was no 
postive signal in HFE145 cell. The result showed that there 
was no expression of FBG2 gene in HFE145 cell too. (×200)
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The results of RT-PCR for FBG2 in MKN45 cell and HFE145 cell Figure 1
The results of RT-PCR for FBG2 in MKN45 cell and HFE145 cell. Note: m1, m2 and m3 were the results of RT-PCR 
for FBG2 in MKN45 cells, h1, h2 were the results of RT-PCR for FBG2 in HFE145 cells. βh was the β-actin control of HFE145 
cell, βm1 and βm2 were β-actin control of MKN45 cells. The results showed that there was not expression of FBG2 gene in 
MKN45 cell or HFE145 cell.
h 1            h 2        m a r k e r           m 1            m 2           m 3            ȕh          ȕm1           ȕm2
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tion, MKN-PC cell clones, HFE-PC cell clones and
untreated cell clones were used as control groups.
Analysis of cell cycle and apoptosis
FBG2 gene stable expression cell groups(MKN-FBG2,
HFE-FBG2), PCDNA3.1 empty vector transfection
groups(MKN-PC, HFE-PC) and untreated cell control
groups were detected by flow cytometry. When the cells
covered 70% of the area of cell culture plates in each
group, serum-free culture medium was used for synchro-
nization. After 24 hours' continuous culture, the cells were
harvested and fixed by 100% ethanol, then prepared for
single cell suspensions. After DNA staining, the cell cycles
of the samples were measured on a FACS Calibur cytome-
ter. The analysis software was CellQuest. After synchroni-
zation and 24 hours' continuous culture, the cells were
harvested and fixed, PI and AnexinV-FITC double staining
was performed, and flow cytometry was used to detect the
apoptosis of cells. 3 replicate tests on every clone were per-
formed in each group, the average values of three groups
were calculated respectively, and comparison between
three groups was conducted.
Colony formation assay
MKN-FBG2, HFE-FBG2, MKN-PC, HFE-PC and untreated
cell control groups were detected. 1000 cells of each clone
were respectively seeded in a 9 cm cell culture dish. After
18 days' culture in DMEM containing fetal calf serum, the
number of cell clones with more than 50 cells was
counted under microscope in each dash (clone formation
rate = number of clones in each dish/1000). Three redu-
plicate dishes were used from each clone. Cell colonies
were then fixed and stained with 0.5% methylene blue
(Sigma, Poole, Dorset, U.K.) in ethanol. All colonies visi-
ble by eye were counted separately for each sample and
evaluated their clone formation rates.
Cell migration assay
Cell migration assays were performed using FCS-coated
polycarbonate filters (8 μm pore size; Transwell)[10]. The
membrane undersurface was coated with 200 μl FCS for 1
hr at 37°C and blocked with 200 μl migration buffer
(0.5% BSA in DMEM) for 30 min at 37°C. The lower
chamber was filled with 500 μl of migration buffer, fol-
lowing which cells were plated in the upper chamber of 4
wells per treatment at a density of 1 × 105 in 100 μl of
migration buffer and incubated at 37°C for 4 hr. Follow-
ing incubation, cells in the upper compartment were
trypsinized and counted by the CASY 1 counter (Sharfe
System, Reutingen, Germany). Cells that had migrated to
the lower surface of the filter were also trypsinized and
counted. The migration rate was obtained by dividing the
The immunohistochemistry results of FBG2 in MKN-PC,  MKN-FBG2, HFE-PC and HFE-FBG2 cell lines Figure 4
The immunohistochemistry results of FBG2 in MKN-
PC, MKN-FBG2, HFE-PC and HFE-FBG2 cell lines. A: 
There was no positive signal in MKN-PC cell. B: There was 
positive signal in MKN-FBG2 cell. The brown positive signals 
were mainly distributed in cytoplasm. C: There was no 
brown positive signal in HFE-PC cell too. D: There was posi-
tive signal in HFE-FBG2 cell and the brown positive signals 
were mainly distributed in cytoplasm and cell membrane. The 
results showed that there were expressions of FBG2 gene in 
MKN-FBG2 and HFE-FBG2 cell lines. (×200)

A A    B 
C  D 
The RT-PCR results of FBG2 in MKN-FBG2 cell and HFE- FBG2 cell Figure 3
The RT-PCR results of FBG2 in MKN-FBG2 cell and 
HFE-FBG2 cell. Note: m1 and m2 were the results of RT-
PCR for FBG2 in MKN-FBG2 cells, h1 and h2 were the 
results of RT-PCR for FBG2 in HFE-FBG2 cells. M0 was the 
result of RT-PCR for FBG2 in MKN-PC and h0 was the 
result of RT-PCR for FBG2 in HFE-PC cells. The results 
showed that there were expressions of FBG2 gene in MKN-
FBG2 cell line and HFE-FBG2 cell line.
                      
        m 1           m 2             h 1           h 2           m 0          h 0           m a r k e r     
FBG2
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cell number in the lower chamber by the sum of the cell
number found in both the lower chamber and the upper
chamber ×100.
Statistics
SPSS11.0 statistical software was used. Two-factor and
one-factor analysis of variance was used for statistical
analysis.
Results
Expression of FBG2 gene in MKN45 and HFE145 cell lines
The expressions of FBG2 gene in gastric adenocarcinoma
cell strain MKN45 and gastric cell strain HFE145 were
detected by RT-PCR and immunocytochemical analysis.
All the results in two cell strains were negative, which indi-
cated that there was no detectable expression of FBG2
gene in untreated MKN45 or HFE145 cells. (Figures 1, 2).
Expression of FBG2 gene in transfectants
The expression of FBG2 gene in MKN-FBG2 and HFE-
FBG2 cells were detected by using RT-PCR, Western blot-
ting and immunocytochemical analysis. The results of RT-
PCR, western blotting and immunocytochemical analysis
showed that the expression of FBG2 gene significantly
increased in MKN-FBG2 and HFE-FBG2 cells when com-
pared with the untreated MKN45 and HFE145 cells or
MKN-PC and HFE-PC cells respectively. On the other
hand, the results of immunocytochemical test showed
that the expression of FBG2 gene in MKN-FBG2 cells was
mainly distributed in cytoplasm and there was no obvious
positive signal in cell nucleus and membrane. But the pos-
itive signals were mainly distributed in cytoplasm and cell
membrane, and there was no obvious positive signal in
cell nucleus in HFE-FBG2 cells (Figures 3, 4, 5).
The influence of FBG2 gene on the growth of cells
The results of cell growth curve assay showed that MKN-
FBG2 and HFE-FBG2 cells grew significantly faster than
untreated MKN45 and HFE145 cells or MKN-PC and HFE-
PC cells respectively (P < 0.05), and there was no signifi-
cant difference between the control groups (Figure 6). At
4, 5, 6 and 7 days after inoculation, the average cell counts
of MKN-FBG2 group were 2.49 × 105, 3.72 × 105, 4.36 ×
105 and 5.01 × 105 respectively, which were significantly
more than those of the two control groups (P < 0.05). The
average cell counts at the same days of HFE-FBG2 group
were 2.33 × 105, 3.21 × 105, 3.82 × 105 and 4.63 × 105
respectively, which were significantly more than those of
the two control groups too (P < 0.05).
Analysis of cell cycle by using flow cytometry
The results of flow cytometry analysis showed that the
proportions of the cells in G2-M phase in the MKN-FBG2
and HFE-FBG2 groups were significantly higher than
those of the control groups (P < 0.05), the proportions of
MKN-FBG2 and HFE-FBG2 cells in S phase were signifi-
cantly lower than those of the control groups (P < 0.05),
and there was no significant difference in the proportions
of cells in other phases between them (Table 1, 2). The
results of the effect of FBG2 upregulation on individual
experiments measuring cell cycle progression were sum-
marized in Tables 1, 2.
Detection of apoptosis using flow cytometry
The apoptosis assay result showed that the average apop-
tosis rates of all cell clones in MKN-FBG2 and HFE-FBG2
groups, MKN-PC, HFE-PC groups and untreated MKN45
and HFE145 groups were 1.66 ± 0.24% and 2.32 ± 0.28%,
1.73 ± 0.33% and 2.71 ± 0.47%, 1.78 ± 0.43% and 2.55 ±
The results of Western blot for FBG2 in MKN-FBG2, MKN-PC, HFE-PC and HFE-FBG2 cell lines Figure 5
The results of Western blot for FBG2 in MKN-FBG2, MKN-PC, HFE-PC and HFE-FBG2 cell lines. A: m1, m2 
were the results of Western blot for FBG2 and β-actin in MKN-FBG2 cells with stable transfection of FBG2 and mp were those 
in MKN-PC cells, and m0 was those in MKN45 cells. B: h1, h2 were the results of Western blot for FBG2 and β-actin in HFE-
FBG2 cells and hp were those in HFE-PC cells, and h0 was those in HFE145 cells. The results showed that there were expres-
sions of FBG2 gene in MKN-FBG2 line and HFE-FBG2 cell line, but no expression in other cell lines.
A B
h 0          h p                     h 1                 h 2  
 
FBG2
 
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0.25% respectively, and there was no statistical significant
difference between them (P > 0.05).
Detection of cell proliferation by using colony formation 
assay
The clone formation rates of the MKN-FBG2 (0.51 ± 0.04)
and HFE145(0.32 ± 0.07) group were significantly higher
than those of their control groups respectively (P < 0.05).
There was no significant difference between these control
groups (P > 0.05) (Figure 7). It is apparent that transfec-
tion with FBG2 gene increased the capacity of these cells
to establish colonies to a highly significant degree.
The influence of FBG2 gene on the invasion of cells
Because individual cell migration is an important charac-
teristic of invasive tumor cells, we examined the effects of
FBG2 modulation on migration. The results showed that
the migration rates of MKN-FBG2, MKN-PC and
untreated MKN45 groups were all about 0.3. The rates of
HFE-FBG2, HFE-PC and untreated HFE145 groups were
about 0.2 (Figure 8). We were unable to observe measur-
able migration differences in the cell migration experi-
ments. (P > 0.05).
Discussion
F-box proteins serve as mediators in targeting bound tar-
get proteins for ubiquitination and destruction. The ubiq-
uitin-dependent proteolytic pathway plays a key role in
the regulation of various short-lived proteins involved in
diverse cellular processes in eukaryotes including cell
cycle progression, morphogenesis, signal transduction
and transcription regulation[11,12]. The primary func-
tion of the ubiquitin-dependent proteolytic system is the
tagging of substrate proteins with ubiquitin, i.e. covalent
attachment of multiple ubiquitin molecules, which
allows the proteasome, a 26S protease complex, to recog-
nize and degrade target proteins. This process involves
several main steps: (1) activation of ubiquitin in a
thioester linkage with ubiquiin-activating enzyme (E1);
(2) ransfer of activated ubiquitin from E1 to active site
cysteine of one of many ubiquitin-conjugated enzymes
(E2s); and finally, (3) conjugation of ubiquitin mainly to
acceptor lysine residue of the target protein forming the
isopeptide bond[13]. The final step in some cases requires
an additional component of the ubiquitin-dependent
Table 1: The different cell cycle of MKN-FBG2, MKN-PC and MKN45 group
Group Clone number n G0--G1(%) G2--M(%) S(%)
MKN-FBG2 12 3 51.66 ± 7.43 21.71 ± 4.29 26.84 ± 4.18
MKN-PC 7 3 47.84 ± 7.07 5.79 ± 2.31 47.16 ± 6.431
MKN45 1 3 44.58 ± 6.54 3.20 ± 1.581 52.78 ± 6.291
(note: compare with the group of MKN-FBG2, 1denoting P < 0.05)
The growth curves of MKN-FBG2, MKN-PC, MKN45, HFE- FBG2, HFE-PC and HFE145 cell lines Figure 6
The growth curves of MKN-FBG2, MKN-PC, MKN45, 
HFE-FBG2, HFE-PC and HFE145 cell lines. A: The 
growth curves of MKN-FBG2, MKN-PC and MKN45 cell 
lines. The unit of vertical axis was × 105 that of horizontal 
axis was the number of days. The results showed that MKN-
FBG2 cells grew faster than its control groups. B: The 
growth curves of HFE-FBG2, HEF-PC and HFE145 cell lines. 
The results showed that HFE-FBG2 cells grew faster than its 
control groups too.
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The result of cell migration assay of MKN45, MKN-PC,  MKN-FBG2, HFE-FBG2, HFE-PC and HFE145 cell lines Figure 8
The result of cell migration assay of MKN45, MKN-
PC, MKN-FBG2, HFE-FBG2, HFE-PC and HFE145 
cell lines. A: 1 was the cell migration rate of MKN45 cell 
line, 2 was that of MKN-PC cell line, 3 was that of MKN-
FBG2 cell line. B: 1 was the cell migration rate of HFE145 cell 
line, 2 was that of HFE-PC cell line, 3 was that of HFE-FBG2 
cell line. The results showed that MKN-FBG2 and HFE-FBG2 
cells could have not more powerfully invasive activity than 
their control groups.
FHOOPLJUDWLRQUDWH










FHOOPLJUDWLRQ
UDWH
A
FHOOPLJUDWLRQUDWH







FHOOPLJUDWLRQ
UDWH
B
Table 2: The different cell cycle of HFE-FBG2, HFE-PC and HFE145 group
Group Clone number n G0--G1(%) G2--M(%) S(%)
HFE-FBG2 9 3 66.27 ± 6.96 18.53 ± 6.61 15.22 ± 3.23
HFE-PC 5 3 62.45 ± 8.33 4.04 ± 1.87(1) 32.95 ± 8.77(1)
HFE145 1 3 71.92 ± 11.18 3.18 ± 0.98(1) 27.31 ± 7.02(1)
(note: compare with the group of HFE-FBG2, (1)denoting P < 0.05)
The result of colony formation assay of MKN45, MKN-PC,  MKN-FBG2, HFE-FBG2, HFE-PC and HFE145 cell lines Figure 7
The result of colony formation assay of MKN45, 
MKN-PC, MKN-FBG2, HFE-FBG2, HFE-PC and 
HFE145 cell lines. A: 1 was the colony formation rate of 
MKN45 cell line, 2 was that of MKN-PC cell line, 3 was that 
of MKN-FBG2 cell line. B: 1 was the colony formation rate of 
HFE145 cell line, 2 was that of HFE-PC cell line, 3 was that of 
HFE-FBG2 cell line. The results showed that MKN-FBG2 and 
HFE-FBG2 cells could have a higher proliferative activity than 
their control groups.
FRORQ\IRUPDWLRQUDWH








FRORQ\IRUPDWLRQ
UDWH
A
FRORQ\IRUPDWLRQUDWH










FRORQ\IRUPDWLRQ
UDWH
BJournal of Experimental & Clinical Cancer Research 2009, 28:78 http://www.jeccr.com/content/28/1/78
Page 8 of 9
(page number not for citation purposes)
proteolytic system, ubiquitin-protein ligase (E3), believed
to be the most directly involved in target protein recogni-
tion and generally composed of several subunits. E3 func-
tions generally as an adapter that interacts with both its
cognate E2 and the protein substrate and thus selects this
substrate for ubiquitination and consequent degradation.
We here describe the roles of one F-box protein named
FBG2, which play some roles in many functions of cells
with other members in F-BOX family participating in the
metabolism of ubiquitin, but there is still lack of research
on this gene previously. Some researches [14] showed that
F-BOX family participated in the degradation of some
anti-oncogenes including P53. The other researches by
Wu Qingming, Zhang Weiguo et al [15,16] also showed
there was a close relation between the metabolic system of
ubiquitin and the proliferation and apoptosis of gastric
cancer cells, so it was suspected that the overexpression of
the genes of this family might be concerned with the for-
mation and development of gastric cancer. The results of
a gene chip research performed by our department also
preliminarily confirmed the upregulation of FBG2 in gas-
tric adenocarcinoma tissues. The gene clone technique
used in this research further verified its functions in gastric
cancer cell line and normal gastric cell line. First, liposome
mediated gene transfection and G418 pressure screening
were used to obtain cell strains with stable transfection of
FBG2 genes, which were verified by immunocytochemis-
try, RT-PCR and Western blotting analysis. Growth curve
assay, colony formation assay and flow cytometry assay
were performed for the functional verification on the gas-
tric cancer cell line and gastric cell line with stable expres-
sion of FBG2. The results of growth curve assay and
colony formation assay showed that the growth and pro-
liferation of the cell strains with stable expression of FBG2
were significantly faster than those of the cells transfected
with empty vectors and untreated control cells not only in
gastric cancer cell line but also in normal gastric cell line.
Therefore, FBG2 gene could accelerate the growth and
proliferation of cells. The reasons might be as follows: (1)
The gene products promoted the activities of the meta-
bolic system of ubiquitin so as to enhance the metabolism
of some protein molecules in cells and accelerate the
growth and proliferation of cells. (2) It might accelerate
the degradation of proteins inhibiting the growth and
proliferation of cells so as to promote the growth and pro-
liferation. The results of flow cytometry assay showed that
the proportions of cells in G2-M phase in the cell strains
with stable expression of FBG2 were higher than those of
the control groups and the proportions of cells in S phase
were lower than those of the control cells. Corinna
Benz[17] thought that F-box proteins could control cell
cycle by adjusting the degradation of some proteins which
controlled cell cycle such as cyclins. The division cycle of
eukaryotic cells is controlled by protein kinases which are
activated by binding to cyclins. Cyclins are present only at
particular times in the cell cycle; after they are no longer
required they are destroyed by ubiquitination followed by
digestion by the proteasome [18-20]. The ubiquitin
chains are added by a cascade of enzymes called E1, E2
and E3 ubiquitin ligases, and specificity is determined by
the E3 components. The E3 ligases that are important for
cell cycle control are the anaphase promoting complex or
cyclosome (APC/C) and the Skp1-Cdc53/cullin-F-box
protein (SCF) complex [21]. In SCF complexes, proteins
with an "F-box" domain (also called "cyclin-like F-box")
link targets to the degradation machinery.
There was no significant difference of the apoptosis rates
between each group. The results indicated that for the cell
strains with stable expression of FBG2, many were in the
division stage, so FBG2 gene could accelerate the growth
and proliferation of cells. However, this gene did not
affect the apoptosis of gastric cancer cells or normal gastric
cells perhaps because FBG2 gene or the metabolic system
of ubiquitin had little influence on the key genes con-
cerned with apoptosis procedure. The results of Transwell
migration assay showed that there was no significant dif-
ference in the migration capacity, which represented the
invasiveness of cells, between each groups of these cells
and the cause needed to be further investigated. A proba-
ble cause was that there was no close relation between the
gene products (proteins) concerned with invasion and
FBG2 gene or the metabolic system of ubiquitin. The
main conclusion of this research is as follows: FBG2 gene
can significantly promote the growth and proliferation of
gastric cancer cells and normal gastric cells and change the
cell cycle of them. There were still many deficiencies in
our research. For example, only a few cell lines were used.
In future researches, the cell lines with high expression of
FBG2 gene will be used for RNAi or antisense and
ribozyme expression inhibition in order to further verify
the functions. Our extensive attempts are to find the capi-
tal ligands and functional route of FBG2 by proteomics
and immunological methods. In addition, animal experi-
ments will also be used to indepthly investigate the rela-
tion between FBG2 gene (even the whole F-BOX family
and the metabolic system of ubiquitin) and the occur-
rence and development of gastric cancer.
Conclusion
The results of the present investigation demonstrated that
FBG2 gene is not expressed in MKN45 or HFE145 cell
lines. The overexpression of the gene can influence some
biological characteristics of gastric cancer cell or normal
gastric cell. FBG2 can promote the growth and prolifera-
tion of these cells and help tumor cell maintain malignant
phenotype. But it can have a negative influence on the
apoptosis or the ability of invasion of gastric cancer cells.
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